Circulating Endothelial Progenitors — Cells as Biomarkers
- 8 September 2005
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 353 (10) , 1055-1057
- https://doi.org/10.1056/nejme058134
Abstract
Endothelial injury and dysfunction are thought to be critical events in the pathogenesis of atherosclerosis. Thus, understanding the mechanisms that maintain and restore endothelial function may have important clinical implications. A series of clinical and basic studies prompted by the discovery of bone marrow–derived endothelial progenitor cells1 have provided insights into these processes and opened a door to the development of new therapeutic approaches.Growing evidence suggests that bone marrow–derived endothelial progenitor cells circulate in the blood and play an important role in the formation of new blood vessels as well as contribute to vascular homeostasis in the adult. Circulating . . .Keywords
This publication has 12 references indexed in Scilit:
- Circulating Endothelial Progenitor Cells and Cardiovascular OutcomesNew England Journal of Medicine, 2005
- Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trialThe Lancet, 2004
- Physical Training Increases Endothelial Progenitor Cells, Inhibits Neointima Formation, and Enhances AngiogenesisCirculation, 2004
- Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cellsNature Medicine, 2003
- Aging, Progenitor Cell Exhaustion, and AtherosclerosisCirculation, 2003
- Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular RiskNew England Journal of Medicine, 2003
- Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery DiseaseCirculation, 2001
- Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac functionNature Medicine, 2001
- Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferonNature Medicine, 1999
- Isolation of Putative Progenitor Endothelial Cells for AngiogenesisScience, 1997